Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies

In the last decade there has been tremendous effort in offering better therapeutic management strategies to patients with hematologic malignancies. These efforts have ranged from biological to clinical approaches and resulted in the rapid development of new approaches. The main “problem” that comes...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Med
Asıl Yazarlar: Constantinescu, Catalin, Pasca, Sergiu, Zimta, Alina-Andreea, Tat, Tiberiu, Rus, Ioana, Teodorescu, Patric, Iluta, Sabina, Tanase, Alina, Colita, Anca, Sigurjonsson, Olafur, Einsele, Hermann, Tomuleasa, Ciprian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Perspective
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7565707/
https://ncbi.nlm.nih.gov/pubmed/32911829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9092903
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller